HK1215541A1 - 治療瘙癢的方法 - Google Patents

治療瘙癢的方法

Info

Publication number
HK1215541A1
HK1215541A1 HK16103523.2A HK16103523A HK1215541A1 HK 1215541 A1 HK1215541 A1 HK 1215541A1 HK 16103523 A HK16103523 A HK 16103523A HK 1215541 A1 HK1215541 A1 HK 1215541A1
Authority
HK
Hong Kong
Prior art keywords
methods
treating pruritus
pruritus
treating
Prior art date
Application number
HK16103523.2A
Other languages
English (en)
Inventor
Thomas Sciascia
Original Assignee
Trevi Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/715,625 external-priority patent/US8637538B1/en
Application filed by Trevi Therapeutics Inc filed Critical Trevi Therapeutics Inc
Publication of HK1215541A1 publication Critical patent/HK1215541A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16103523.2A 2012-12-14 2016-03-24 治療瘙癢的方法 HK1215541A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261737488P 2012-12-14 2012-12-14
US13/715,625 US8637538B1 (en) 2012-12-14 2012-12-14 Methods for treatment of pruritis
PCT/US2013/075096 WO2014093871A1 (en) 2012-12-14 2013-12-13 Methods for treating pruritus

Publications (1)

Publication Number Publication Date
HK1215541A1 true HK1215541A1 (zh) 2016-09-02

Family

ID=50935003

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103523.2A HK1215541A1 (zh) 2012-12-14 2016-03-24 治療瘙癢的方法

Country Status (13)

Country Link
EP (1) EP2931279B1 (zh)
JP (4) JP2016506398A (zh)
KR (3) KR20150093702A (zh)
CN (2) CN110585209A (zh)
AU (2) AU2013359017B2 (zh)
BR (1) BR112015013984A2 (zh)
CA (1) CA2892393C (zh)
HK (1) HK1215541A1 (zh)
MX (1) MX2015007518A (zh)
NZ (1) NZ708371A (zh)
RU (1) RU2015128265A (zh)
WO (1) WO2014093871A1 (zh)
ZA (2) ZA201504229B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
RU2015128265A (ru) * 2012-12-14 2017-01-25 Треви Терапьютикс, Инк. Способы лечения зуда
US20140179727A1 (en) 2012-12-14 2014-06-26 Trevi Therapeutics, Inc. Methods for treating pruritus
BR112016029236A2 (pt) * 2014-06-13 2017-11-07 Trevi Therapeutics Inc métodos para tratar prurido.
WO2016196928A1 (en) 2015-06-04 2016-12-08 PellePharm, Inc. Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
TW201725041A (zh) * 2016-01-04 2017-07-16 懷特生技新藥股份有限公司 治療皮膚癢之醫藥組合物
CN105560202B (zh) * 2016-03-11 2019-05-24 广州玻思韬控释药业有限公司 一种盐酸纳布啡凝胶骨架缓释片的制备方法及应用
US20180008592A1 (en) * 2016-03-21 2018-01-11 Trevi Therapeutics, Inc. Treatment of uremic pruritus
MX2019004804A (es) * 2016-10-25 2019-08-22 Trevi Therapeutics Inc Tratamiento para el prurigo nodula.
AU2019309913A1 (en) 2018-07-23 2021-03-11 Trevi Therapeutics, Inc. Treatment of chronic cough, breathlessness and dyspnea

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE263563T1 (de) * 1996-11-25 2004-04-15 Toray Industries Mittel gegen juckreiz
US20030054030A1 (en) * 2001-09-13 2003-03-20 Gary Gordon Method and compositions for the treatment of pruritus
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine
EP2425823A1 (en) * 2002-04-05 2012-03-07 Euro-Celtique S.A. Pharmaceutical preparation containing oxycodone and naloxone
EP1763349A2 (en) * 2004-06-03 2007-03-21 Jonathan J. Burbaum Pharmaceutical compositions for the treatment of pruritus
US8394812B2 (en) * 2005-08-24 2013-03-12 Penwest Pharmaceuticals Co. Sustained release formulations of nalbuphine
HUE053838T2 (hu) * 2005-08-24 2021-07-28 Endo Pharmaceuticals Inc Nyújtott felszabadulású nabulfin-készítmények
FR2963889B1 (fr) * 2010-08-20 2013-04-12 Debregeas Et Associes Pharma Formulations a base de nalbuphine et leurs utilisations
RU2015128265A (ru) * 2012-12-14 2017-01-25 Треви Терапьютикс, Инк. Способы лечения зуда

Also Published As

Publication number Publication date
JP2022105095A (ja) 2022-07-12
BR112015013984A2 (pt) 2017-07-11
CN104981246A (zh) 2015-10-14
CA2892393A1 (en) 2014-06-19
NZ708371A (en) 2020-05-29
JP7072280B2 (ja) 2022-05-20
JP2021020947A (ja) 2021-02-18
RU2015128265A (ru) 2017-01-25
KR20150093702A (ko) 2015-08-18
AU2018214098A1 (en) 2018-08-30
EP2931279A4 (en) 2016-05-11
JP2016506398A (ja) 2016-03-03
MX2015007518A (es) 2016-03-01
AU2018214098B2 (en) 2019-04-18
EP2931279A1 (en) 2015-10-21
JP2019131588A (ja) 2019-08-08
CN110585209A (zh) 2019-12-20
EP2931279B1 (en) 2024-03-20
KR20210050585A (ko) 2021-05-07
JP6823857B2 (ja) 2021-02-03
AU2013359017B2 (en) 2018-05-10
AU2013359017A1 (en) 2015-06-11
ZA201504229B (en) 2021-07-28
ZA201906339B (en) 2021-07-28
CA2892393C (en) 2021-06-08
KR20220044385A (ko) 2022-04-07
WO2014093871A1 (en) 2014-06-19

Similar Documents

Publication Publication Date Title
HK1214504A1 (zh) 用於治療貧血的方法
ZA201906339B (en) Methods for treating pruritus
PL2839230T3 (pl) Instalacja do obróbki obiektów
EP2830648A4 (en) METHODS OF TREATING NEOPLASIA
GB201212937D0 (en) Method
GB201212932D0 (en) Method
HK1209319A1 (zh) 用於治療丙型肝炎的方法
GB201220940D0 (en) Method P
GB201213636D0 (en) Method
GB201212934D0 (en) Method
GB201210858D0 (en) Method
EP2880048A4 (en) METHOD
GB201202198D0 (en) Method
HK1209320A1 (zh) 用於治療丙型肝炎的方法
ZA201406172B (en) Compounds and methods for treating leukemia
GB201211393D0 (en) Method
HK1209040A1 (zh) 用於治療前庭毒性的方法
GB201214029D0 (en) method
GB201210147D0 (en) Method
EP2854774A4 (en) METHODS OF TREATING INSOMNIA
GB201213858D0 (en) Method
GB201203337D0 (en) Method
GB201201332D0 (en) Method
EP2639418A4 (en) EXHAUST HEATING METHOD
EP2838532A4 (en) PROCESS FOR TREATING SCLERRODERY